Trials / Completed
CompletedNCT00611260
Improvement in Clinical Outcomes in Heart Failure Patients With ICDs That Practice Meditation
Does Meditation Improve Outcomes in Patients With Heart Failure Who Received Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a trial to examine the effects of meditation on the incidence of ventricular arrhythmias and the psychological profiles in patients with implanted cardiac defibrillators. We wish to test the following hypotheses: 1. Vipassana meditation reduces the incidence of atrial and ventricular arrhythmias in patients with congestive heart failure. 2. Vipassana meditation improves the psychological profile in patients with CHF. In this study, subjects meeting the inclusion and exclusion criteria will be recruited into the study after obtaining informed consent. The subjects will then be randomized into either an experimental group ( Meditation) or into a control group (usual care).
Detailed description
This is a single center, investigator-initiated, randomized, controlled trial to examine the effects of meditation on the incidence of ventricular arrhythmias and the psychological profiles in patients with implanted cardiac defibrillators and cardiac resynchronization devices. The former are used to protect patients against cardiac fibrillation and the latter for synchronizing the contractions of the two ventricles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Vipassana Meditation practice and instruction | 2-3 instructed meditation sessions per week in addition to standard medical care. |
| OTHER | Standard Medical Care | Standard medical care for patients with congestive heart failure plus implanted cardiac defibrillators. |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2008-02-08
- Last updated
- 2017-05-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00611260. Inclusion in this directory is not an endorsement.